Driscoll C, Rich J, Isaacson D, Nicolas J, Jiang Y, Mi X
Cancers (Basel). 2025; 17(3).
PMID: 39941759
PMC: 11815771.
DOI: 10.3390/cancers17030390.
Foller S, Regett N, Lataster L, Radziwill G, Takors R
Appl Microbiol Biotechnol. 2024; 108(1):530.
PMID: 39636393
PMC: 11621146.
DOI: 10.1007/s00253-024-13363-4.
Estrada-Almeida A, Castrejon-Godinez M, Mussali-Galante P, Tovar-Sanchez E, Rodriguez A
J Xenobiot. 2024; 14(4):1465-1518.
PMID: 39449423
PMC: 11503348.
DOI: 10.3390/jox14040082.
Hsieh Y, Guan H, Lin C, Huang T, Chuankhayan P, Chen N
JACS Au. 2024; 4(6):2130-2150.
PMID: 38938812
PMC: 11200250.
DOI: 10.1021/jacsau.4c00004.
Han Y, Desai A, Zupancic J, Smith M, Tessier P, Ruotolo B
Protein Sci. 2024; 33(6):e5008.
PMID: 38723181
PMC: 11081520.
DOI: 10.1002/pro.5008.
Modular design of bi- and multi-specific knob domain fusions.
Kuravsky M, Gibbons G, Joyce C, Scott-Tucker A, Macpherson A, Lawson A
Front Immunol. 2024; 15:1384467.
PMID: 38605965
PMC: 11008599.
DOI: 10.3389/fimmu.2024.1384467.
The landscape of small-molecule prodrugs.
Fralish Z, Chen A, Khan S, Zhou P, Reker D
Nat Rev Drug Discov. 2024; 23(5):365-380.
PMID: 38565913
DOI: 10.1038/s41573-024-00914-7.
Untethered shape-changing devices in the gastrointestinal tract.
Liu W, Choi S, George D, Li L, Zhong Z, Zhang R
Expert Opin Drug Deliv. 2023; 20(12):1801-1822.
PMID: 38044866
PMC: 10872387.
DOI: 10.1080/17425247.2023.2291450.
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
Jyssum I, Gehin J, Sexton J, Kristianslund E, Hu Y, Warren D
Rheumatology (Oxford). 2023; 63(6):1746-1755.
PMID: 37773994
PMC: 11147536.
DOI: 10.1093/rheumatology/kead525.
Targeted modulation of immune cells and tissues using engineered biomaterials.
Yousefpour P, Ni K, Irvine D
Nat Rev Bioeng. 2023; 1(2):107-124.
PMID: 37772035
PMC: 10538251.
DOI: 10.1038/s44222-022-00016-2.
Deep Mining of Complex Antibody Phage Pools.
Tulika T, Ljungars A
Methods Mol Biol. 2023; 2702:419-431.
PMID: 37679633
DOI: 10.1007/978-1-0716-3381-6_22.
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond.
Siegmund D, Wajant H
Nat Rev Rheumatol. 2023; 19(9):576-591.
PMID: 37542139
DOI: 10.1038/s41584-023-01002-7.
Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation.
Gackowski M, Madriwala B, Studzinska R, Koba M
Molecules. 2023; 28(13).
PMID: 37446638
PMC: 10343598.
DOI: 10.3390/molecules28134977.
Versatile delivery platform for nucleic acids, negatively charged protein drugs, and genome-editing ribonucleoproteins using a multi-step transformable polyrotaxane.
Taharabaru T, Kihara T, Onodera R, Kogo T, Wen Y, Li J
Mater Today Bio. 2023; 20:100690.
PMID: 37441133
PMC: 10333717.
DOI: 10.1016/j.mtbio.2023.100690.
Molecular Farming of Pembrolizumab and Nivolumab.
Stark M, Joubert A, Visagie M
Int J Mol Sci. 2023; 24(12).
PMID: 37373192
PMC: 10298108.
DOI: 10.3390/ijms241210045.
Experimental and computational analysis of the injection-induced mechanical changes in the skin microenvironment during subcutaneous injection of biologics.
Shen Y, Shah S, Zhao K, Han B
Extreme Mech Lett. 2023; 61.
PMID: 37304308
PMC: 10249613.
DOI: 10.1016/j.eml.2023.102025.
Re-evaluation of FDA-approved antibiotics with increased diagnostic accuracy for assessment of antimicrobial resistance.
Heithoff D, Barnes V L, Mahan S, Fried J, Fitzgibbons L, House J
Cell Rep Med. 2023; 4(5):101023.
PMID: 37116500
PMC: 10213814.
DOI: 10.1016/j.xcrm.2023.101023.
Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021.
Shin Y, Kumar A, Guo J
Clin Drug Investig. 2023; 43(4):289-298.
PMID: 37005969
PMC: 10066981.
DOI: 10.1007/s40261-023-01254-x.
Tackling Issues Observed during the Development of a Liquid Chromatography Method for Small Molecule Quantification in Antibody-Chelator Conjugate.
Bouvarel T, Bremeyer N, Gao M, Holkenjans W, Hetzel T, Pell R
Molecules. 2023; 28(6).
PMID: 36985597
PMC: 10055815.
DOI: 10.3390/molecules28062626.
Biomaterials-Mediated Engineering of the Immune System.
Backlund C, Jalili-Firoozinezhad S, Kim B, Irvine D
Annu Rev Immunol. 2023; 41:153-179.
PMID: 36696570
PMC: 10375298.
DOI: 10.1146/annurev-immunol-101721-040259.
